• Something wrong with this record ?

Long-term outcomes of intravenous fibrinolysis in central retinal artery occlusion

P. Kozner, L. Eichenmann, M. Ceska Burdova, M. Pavlikova, M. Hlozanek, D. Dotrelova

. 2023 ; 13 (1) : 20505. [pub] 20231122

Language English Country England, Great Britain

Document type Observational Study, Journal Article

Grant support
00064203 Ministerstvo Zdravotnictví Ceské Republiky

Central retinal artery occlusion (CRAO) is an ophthalmologic emergency that can lead to irreversible loss of vision. Intravenous thrombolysis (IVT) has been used experimentally for its treatment. Our study aimed to evaluate the effect of emergency IVT on CRAO and its impact on visual acuity outcomes. We conducted a retrospective observational study of patients with CRAO. A total of 46 patients with CRAO were analysed; 16 patients received IVT treatment (IVT group) while 30 did not (no-IVT group). Seven patients from the IVT group received IVT early, within 4.5 hours (h) after the onset of symptoms (early-IVT), and 9 patients received it beyond this timeframe (late-IVT). The median time-to-hospital was 8.5 h: 3 h for the IVT group and 24 h for the no-IVT group. The median time-to-treatment was 5 h. The median outcome of visual acuity was 0.05 in the early-IVT, 0.025 in the late-IVT, and 0.01 in the no-IVT group. Among patients who received IVT early, 86% exhibited significant visual improvement. This improvement was four-fold greater compared to all other groups (p = 0.040), including the late-IVT (p = 0.011) and no-IVT groups (p = 0.023). No complications of the treatment were reported. Our study confirms that the administration of IVT treatment for CRAO within the 4.5-h time window is both safe and effective.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000629
003      
CZ-PrNML
005      
20240213093307.0
007      
ta
008      
240109s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-023-47987-9 $2 doi
035    __
$a (PubMed)37993533
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kozner, Pavel $u Department of Ophthalmology, Second Faculty of Medicine Charles University and Motol University Hospital in Prague, V Uvalu 84, 150 06, Prague, Czech Republic. pavel.kozner@fnmotol.cz
245    10
$a Long-term outcomes of intravenous fibrinolysis in central retinal artery occlusion / $c P. Kozner, L. Eichenmann, M. Ceska Burdova, M. Pavlikova, M. Hlozanek, D. Dotrelova
520    9_
$a Central retinal artery occlusion (CRAO) is an ophthalmologic emergency that can lead to irreversible loss of vision. Intravenous thrombolysis (IVT) has been used experimentally for its treatment. Our study aimed to evaluate the effect of emergency IVT on CRAO and its impact on visual acuity outcomes. We conducted a retrospective observational study of patients with CRAO. A total of 46 patients with CRAO were analysed; 16 patients received IVT treatment (IVT group) while 30 did not (no-IVT group). Seven patients from the IVT group received IVT early, within 4.5 hours (h) after the onset of symptoms (early-IVT), and 9 patients received it beyond this timeframe (late-IVT). The median time-to-hospital was 8.5 h: 3 h for the IVT group and 24 h for the no-IVT group. The median time-to-treatment was 5 h. The median outcome of visual acuity was 0.05 in the early-IVT, 0.025 in the late-IVT, and 0.01 in the no-IVT group. Among patients who received IVT early, 86% exhibited significant visual improvement. This improvement was four-fold greater compared to all other groups (p = 0.040), including the late-IVT (p = 0.011) and no-IVT groups (p = 0.023). No complications of the treatment were reported. Our study confirms that the administration of IVT treatment for CRAO within the 4.5-h time window is both safe and effective.
650    _2
$a lidé $7 D006801
650    12
$a fibrinolýza $7 D005342
650    _2
$a trombolytická terapie $x škodlivé účinky $7 D015912
650    12
$a okluze retinální arterie $x farmakoterapie $7 D015356
650    _2
$a fibrinolytická aktivita $7 D063285
650    _2
$a intravenózní podání $7 D061605
650    _2
$a výsledek terapie $7 D016896
655    _2
$a pozorovací studie $7 D064888
655    _2
$a časopisecké články $7 D016428
700    1_
$a Eichenmann, Libor $u Department of Ophthalmology, Second Faculty of Medicine Charles University and Motol University Hospital in Prague, V Uvalu 84, 150 06, Prague, Czech Republic
700    1_
$a Ceska Burdova, Marie $u Department of Ophthalmology, Second Faculty of Medicine Charles University and Motol University Hospital in Prague, V Uvalu 84, 150 06, Prague, Czech Republic
700    1_
$a Pavlikova, Marketa $u Department of Probability and Mathematical Statistics, Faculty of Mathematics and Physics, Charles University in Prague, Prague, Czech Republic
700    1_
$a Hlozanek, Martin $u Department of Ophthalmology, Second Faculty of Medicine Charles University and Motol University Hospital in Prague, V Uvalu 84, 150 06, Prague, Czech Republic
700    1_
$a Dotrelova, Dagmar $u Department of Ophthalmology, Second Faculty of Medicine Charles University and Motol University Hospital in Prague, V Uvalu 84, 150 06, Prague, Czech Republic
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 13, č. 1 (2023), s. 20505
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37993533 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213093304 $b ABA008
999    __
$a ok $b bmc $g 2049340 $s 1210323
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 13 $c 1 $d 20505 $e 20231122 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
GRA    __
$a 00064203 $p Ministerstvo Zdravotnictví Ceské Republiky
LZP    __
$a Pubmed-20240109

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...